US Patent Issued to PHARMALA BIOTECH on July 14 for "Processes for the preparation of the enantiomers of 3,4-methylenedioxymethamphetamine (MDMA) and N-methyl-1,3-benzodioxolylbutanamine (MBDB)" (Canadian Inventor)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,817, issued on July 14, was assigned to PHARMALA BIOTECH INC. (Vancouver, Canada).

"Processes for the preparation of the enantiomers of 3,4-methylenedioxymethamphetamine (MDMA) and N-methyl-1,3-benzodioxolylbutanamine (MBDB)" was invented by Tao Xin (Woodbridge, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application includes processes for preparing the (R)- or (S)-enantiomers of 3,4-methylenedioxymethamphetamine (MDMA) and the (R)- or (S)-enantiomers of N-methyl-1,3-benzodioxolylbutanamine (MBDB) starting with the alkyl esters of 3,4-dihydroxy-L-phenylalanine (L-DOPA) or alkyl esters of 3,4-dihydroxy-L-phenylalanine (D-DOPA), ...